Stanford Regulating Circuits of the Brain Study - MDMA
NCT04060108 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22
Last updated 2026-01-02
Summary
This study is a biomarker study designed to characterize how human neural circuits and behaviors are modified during altered states induced by MDMA.
Conditions
- Healthy
Interventions
- DRUG
-
80mg, 120mg, Placebo
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH - collaborator INDUSTRY
- lead OTHER
Principal Investigators
-
Leanne M Williams, PhD · Stanford PI
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-11-02
- Primary Completion
- 2024-01-01
- Completion
- 2024-01-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Study of the Effects of MDMA/Ecstasy on Water Regulation, Sleep, and Cognition.
NCT01053403 ·Status: COMPLETED ·Phase: NA
-
Effects of MDMA-like Substances in Healthy Subjects
NCT04847206 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of MDMA on Social and Emotional Processing
NCT01849419 ·Status: COMPLETED ·Phase: NA
-
Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial
NCT01458327 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects
NCT04516902 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
NCT05379959 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Neurobiology and Pharmacokinets of Acute MDMA Administration
NCT01148342 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Acute Effects of R-MDMA and S-MDMA in Healthy Participants
NCT06905652 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study
NCT01951508 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Drugs on Responses to Brain and Emotional Processes
NCT04053036 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Acute Effects of R- and S-MDMA in Healthy Subjects
NCT05277636 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging
NCT01296802 ·Status: COMPLETED ·Phase: NA
-
Brain Function in Response to Motivational Stimuli
NCT00047866 ·Status: COMPLETED
-
Effect of Methylenedioxymethamphetamine (MDMA) (Serotonin Release) on Fear Extinction
NCT03527316 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Emotional Effects of Methylphenidate and MDMA in Healthy Subjects
NCT01465685 ·Status: COMPLETED ·Phase: PHASE1
-
MDMA in Borderline Personality Disorder
NCT06683014 ·Status: RECRUITING ·Phase: PHASE2
-
Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD
NCT01793610 ·Status: COMPLETED ·Phase: PHASE2
-
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
NCT06624137 ·Status: RECRUITING
-
The NeXT Study; The Netherlands XTC Toxicity Study
NCT00235768 ·Status: COMPLETED
-
Effects of MDMA and Methylphenidate on Social Cognition
NCT01616407 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD.
NCT03752918 ·Status: WITHDRAWN ·Phase: PHASE1
-
Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects
NCT06884514 ·Status: RECRUITING ·Phase: PHASE1
-
Role of Serotonin in Acute and Subacute MDMA Effects
NCT00838305 ·Status: COMPLETED ·Phase: NA
-
Prosocial Effects of MDMA
NCT05948683 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)
NCT00886886 ·Status: COMPLETED ·Phase: PHASE1